Renal Cancer - Results from #5180

Phase 3 Trial of Opdivo in Combination with CABOMETYX or Opdivo and Yervoy in Combination with CABOMETYX, Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma July 10, 2017

[Prognostic factors in renal cancer with venous thrombus survival analysis.] July 10, 2017

Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma July 10, 2017

Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center July 7, 2017

Nephrotic Syndrome With Cancer Immunotherapies: A Report of 2 Cases July 7, 2017

Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer July 7, 2017

Coffee consumption and risk of renal cell carcinoma July 7, 2017

Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee. July 6, 2017

Association of decreased mean platelet volume with renal cell carcinoma July 6, 2017

Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimen July 6, 2017

Rapid Progressive Disease After Nivolumab Therapy in Three Patients with Metastatic Renal Cell Carcinoma July 6, 2017

Resolution of a Debilitating Paraneoplastic Parkinson-like Neurological Syndrome Following Tyrosine Inhibitor Therapy and Consolidative Nephrectomy in a Patient with Advanced Clear Cell Renal Cell Carcinoma. July 5, 2017

Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors July 5, 2017

A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma July 5, 2017

Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass July 5, 2017

The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study July 5, 2017

Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation July 4, 2017

Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel July 4, 2017

Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy-a controlled feasibility trial July 3, 2017

Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring July 3, 2017

Page 260 of 460